• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Implantation of dual chamber pacemaker defibrillator and placement of endocardial leads via the axillary vein.

作者信息

Yang J, Powell A, Davis M

机构信息

Department of Cardiology, Beijing Hospital, Beijing 100730, China.

出版信息

Chin Med J (Engl). 2001 Jun;114(6):568-70.

PMID:11780428
Abstract

OBJECTIVES

To assess the preliminary clinical results of implantation of dual chamber pacemaker defibrillator and to evaluate the safety and effectiveness of placement of endocardial leads in the axillary vein.

METHODS

Seven patients with ventricular tachycardia and/or ventricular fibrillation (VT/VF), associated with bradyanhythmia received implantation of a dual chamber pacemaker defibrillator, including 5 patients with coronary artery disease and 2 patients with dilated cardiomyopathy. The atrial and ventricular leads were introduced via the axillary vein under venographic guidance.

RESULTS

Dual chamber pacemaker defibrillators were successfully implanted in the left chest subcutaneous pocket in 5 patients and the left pectoral muscular pocket in 2 patients. All the VT/VF occurring either inducibly during the procedure or spontaneuously during follow-up were detected promptly and treated successfully. Both the pacing and sensing functions were satisfactory. The endocardial leads required were successfully introduced via the axillary vein without major complications.

CONCLUSIONS

Dual chamber pacemaker defibrillators can provide reliable therapy for VT/VF and the dual chamber pacing function. Placement of endocardial leads via the axillary vein under venographic guidance is safe and effective.

摘要

相似文献

1
Implantation of dual chamber pacemaker defibrillator and placement of endocardial leads via the axillary vein.
Chin Med J (Engl). 2001 Jun;114(6):568-70.
2
The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.双腔与VVI植入式心脏除颤器(DAVID)试验:原理、设计、结果、临床意义及对未来试验的启示
Card Electrophysiol Rev. 2003 Dec;7(4):468-72. doi: 10.1023/B:CEPR.0000023165.20987.b1.
3
[The concurrent implantation of a last-generation automatic defibrillator and a 2-chamber pacemaker].[同时植入新一代自动除颤器和双腔起搏器]
G Ital Cardiol. 1998 Aug;28(8):878-86.
4
[Dual-chamber implantable automatic defibrillators. Experiences apropos of 16 cases].[双腔植入式自动除颤器。关于16例的经验]
Arch Mal Coeur Vaiss. 1998 Jun;91(6):739-44.
5
An approach to ablate and pace:AV junction ablation and pacemaker implantation performed concurrently from the same venous access site.一种消融与起搏的方法:经同一静脉入路同时进行房室结消融和起搏器植入。
Pacing Clin Electrophysiol. 2007 Sep;30(9):1116-20. doi: 10.1111/j.1540-8159.2007.00822.x.
6
Device management of arrhythmias after Fontan conversion.Fontan转换术后心律失常的器械管理
J Thorac Cardiovasc Surg. 2009 Oct;138(4):937-40. doi: 10.1016/j.jtcvs.2008.11.066. Epub 2009 Jun 17.
7
Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study.用于植入式除颤器心律诊断的双腔与单腔检测增强:检测室上性心动过速研究
Circulation. 2006 Jun 27;113(25):2871-9. doi: 10.1161/CIRCULATIONAHA.105.594531. Epub 2006 Jun 12.
8
The implantable cardioverter defibrillator: technology, indications, and impact on cardiovascular survival.
Curr Probl Cardiol. 2004 Jun;29(6):303-56. doi: 10.1016/j.cpcardiol.2004.02.003.
9
Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).影响植入式除颤器对室性心动过速/心室颤动恰当放电的因素:多中心自动除颤器植入试验II(MADIT-II)的研究结果
J Am Coll Cardiol. 2005 Nov 1;46(9):1712-20. doi: 10.1016/j.jacc.2005.05.088. Epub 2005 Oct 10.
10
Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).大多数植入式心脏复律除颤器/心脏再同步治疗除颤器患者可行无诱导或有限电击测试:多中心ASSURE研究(心律失常单次电击除颤阈值测试与易损性上限:植入式心脏复律除颤器植入的风险降低评估)结果
Circulation. 2007 May 8;115(18):2382-9. doi: 10.1161/CIRCULATIONAHA.106.663112. Epub 2007 Apr 30.